BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35033442)

  • 1. Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease.
    Nørgaard CH; Starkopf L; Gerds TA; Malmborg M; Bonde AN; Zareini B; Mills EHA; Vestergaard P; Wong ND; Torp-Pedersen C; Lee CJ
    J Diabetes Complications; 2022 Feb; 36(2):108126. PubMed ID: 35033442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013).
    Jung CH; Chung JO; Han K; Ko SH; Ko KS; Park JY;
    Cardiovasc Diabetol; 2017 Jan; 16(1):1. PubMed ID: 28057001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between migraine and major cardiovascular events in type 2 diabetes mellitus.
    Cheon DY; Han K; Yang YS; Kim Y; Lee SH; Kim C; Sohn JH; Oh MS; Lee BC; Lee M; Yu KH
    Cardiovasc Diabetol; 2022 Dec; 21(1):275. PubMed ID: 36494651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.
    Sattar N; Rawshani A; Franzén S; Rawshani A; Svensson AM; Rosengren A; McGuire DK; Eliasson B; Gudbjörnsdottir S
    Circulation; 2019 May; 139(19):2228-2237. PubMed ID: 30955347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank.
    Boonpor J; Pell JP; Ho FK; Celis-Morales C; Gray SR
    Diabetes Obes Metab; 2024 Feb; 26(2):524-531. PubMed ID: 37881162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus.
    Gyldenkerne C; Mortensen MB; Kahlert J; Thrane PG; Warnakula Olesen KK; Sørensen HT; Thomsen RW; Maeng M
    J Am Coll Cardiol; 2023 Oct; 82(16):1583-1594. PubMed ID: 37821168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Peng CH; Yang YS; Chan KC; Kornelius E; Chiou JY; Huang CN
    Intern Med; 2017; 56(9):1015-1021. PubMed ID: 28458305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study.
    Gooden TE; Gardner M; Wang J; Jolly K; Lane DA; Benjamin LA; Mwandumba HC; Kandoole V; Lwanga IB; Taylor S; Manaseki-Holland S; Lip GYH; Nirantharakumar K; Thomas GN
    J Infect Dis; 2022 Apr; 225(8):1348-1356. PubMed ID: 34417792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohorts.
    Mühlenbruch K; Menzel J; Dörr M; Ittermann T; Meisinger C; Peters A; Kluttig A; Medenwald D; Bergmann M; Boeing H; Schulze MB; Weikert C
    Sci Rep; 2020 Sep; 10(1):15373. PubMed ID: 32958955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients.
    Eguchi K; Hoshide S; Ishikawa S; Shimada K; Kario K
    Diabetes Res Clin Pract; 2012 Dec; 98(3):518-23. PubMed ID: 23020940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
    Rawshani A; Sattar N; Franzén S; Rawshani A; Hattersley AT; Svensson AM; Eliasson B; Gudbjörnsdottir S
    Lancet; 2018 Aug; 392(10146):477-486. PubMed ID: 30129464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
    Østergaard HB; Hageman SHJ; Read SH; Taylor O; Pennells L; Kaptoge S; Petitjean C; Xu Z; Shi F; McEvoy JW; Herrington W; Visseren FLJ; Wood A; Eliasson B; Sattar N; Wild S; Di Angelantonio E; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Jan; 30(1):61-69. PubMed ID: 36208182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Survival After First Myocardial Infarction in People With Diabetes.
    Glynn L; Lind M; Andersson T; Eliasson B; Hofmann R; Nyström T
    J Am Heart Assoc; 2024 May; 13(10):e034741. PubMed ID: 38761078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic position and first-time major cardiovascular event in patients with type 2 diabetes: a Danish nationwide cohort study.
    Falkentoft AC; Zareini B; Andersen J; Wichmand C; Hansen TB; Selmer C; Schou M; Gæde PH; Staehr PB; Hlatky MA; Torp-Pedersen C; Gislason GH; Gerds TA; Bruun NE; Ruwald AC
    Eur J Prev Cardiol; 2022 Jan; 28(16):1819-1828. PubMed ID: 34037228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study.
    Long GH; Cooper AJ; Wareham NJ; Griffin SJ; Simmons RK
    Diabetes Care; 2014 Jun; 37(6):1712-20. PubMed ID: 24658389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
    Kaushik P; Solomon DH; Greenberg JD; Anderson JT; Reed G; Pala O; Sumbul-Yuksel B; Kadam P; Kremer JM;
    Clin Rheumatol; 2015 Oct; 34(10):1697-704. PubMed ID: 26242470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.